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remaining two could not be assayed by RT-PCR.
One discordant sample that was reactive only by
the TRI-DOT assay was non-reactive by repeat
ELISA, Western blot, VIDAS DUO and RT-PCR;
this was considered to be a false-positive result by
the TRI-DOT kit. Thus, compared with the fourth-
generation ELISA, the TRI-DOT Rapid HIV test
had a speciﬁcity of 99.9% and a sensitivity of
99.5%. The overall prevalence of HIV-1 and HIV-2
in the sera studied was 4.7% and 0.2%, respect-
ively, and 19 (1.7%) of the 1150 HIV-positive
patients were infected with both HIV-1 and HIV-2.
The CDC has advocated routine testing of
patients for HIV as a means of increasing provider
vigilance and reducing occupational exposure [12].
The results are also helpful in making patients
aware of their infection and enabling appropriate
treatment and counselling [12,13]. Early diagnosis
of HIV infection is the cornerstone of prevention
and care strategies for HIV-infected individuals.
The rapid test used in the present study only
detects HIV antibodies, and not the p24 antigen;
thus there is always the possibility of missing a
recent infection when the p24 antigen is present,
but without any detectable antibody levels. The
results of the study indicated that the TRI-DOT
HIV test failed to detect only six (0.5%) of 1150
reactive sera; these six sera were presumably from
patients who were in the early stages of infection.
Thus the TRI-DOTHIV Rapid assay, which gives a
result within 10 min, can be used in emergency
situations when there is insufﬁcient time to per-
form a fourth-generation ELISA. However, the
results should later be conﬁrmed by ELISA to rule
out the possibility of early infection. The two tests
showed good sensitivity for bothHIV-1 andHIV-2.
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ABSTRACT
Between December 1999 and December 2004,
40 081 pregnant women were examined for toxo-
plasmosis with Toxo-IgG, Toxo-IgM enzyme
immunoassay. Women with positive results were
then retested with the Toxo-IgG avidity assay for
recent toxoplasmosis. Recent acute toxoplasmosis
in pregnant women was found to be signiﬁcantly
more frequent (p < 0.01) during winter than
summer. The incidence of acute toxoplasmosis
during winter–spring was also signiﬁcantly
more frequent (p < 0.025) than summer–autumn.
This phenomenon should be taken into account
when formulating preventive measures for toxo-
plasmosis, especially for pregnant women.
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Toxoplasmosis, caused by the parasite Toxoplasma
gondii, is usually asymptomatic in healthy adults,
but may cause severe disease in immunocompro-
mised individuals and neonates. The infection is
usually contracted via the ingestion of under-
cooked meat containing Toxoplasma cysts, or of
food or water contaminated with Toxoplasma
oocysts from the faeces of infected cats. It is
known that the incidence and prevalence of
infection with Toxoplasma vary among different
populations, probably because of the cultural
traditions and eating habits of particular coun-
tries, varying hygiene standards, differences in
cat densities, and prevailing climatic conditions
[1,2]. There are few published data regarding
seasonal variations in the incidence of acute
human toxoplasmosis. Therefore, the aim of the
present study was to investigate whether seasonal
variations contributed to the risk of acute toxo-
plasmosis among pregnant women in the central
area of Slovenia.
Between 22 December 1999 and 21 December
2004, 40 081 pregnant women from the central
area of Slovenia were examined for acute toxo-
plasmosis during the different seasons of each
year (Table 1), using an enzyme immunoassay
(Toxo-IgG EIA, Toxo-IgM EIA recomb; Cobas-
Core, Roche, Mannheim, Germany). As IgM
antibodies can either decrease to low or undetect-
able levels within a few months or remain
elevated for at least 2 years, it is sometimes
difﬁcult to estimate the precise time of occurrence
of Toxoplasma infection. In order to differentiate
recent Toxoplasma infections, all IgG- and IgM-
positive sera were retested using the Toxo-IgG
avidity assay (Bouty, Milan, Italy). Low avidity
values in this test (< 15%) indicated recent acute
Toxoplasma infection; an equivocal result (15–
25%) suggested primary infection during the
preceding 6 months; and high avidity values
(> 25%) excluded primary infection within the
preceding 3 months [3]. Therefore, women with
equivocal or high avidity values were not inclu-
ded in this study of recent infections.
Slovenia has a very diverse climate, according
to which four main regions can be distin-
guished: the littoral, alpine, central and eastern
areas. Pregnant women from the continental
central area (average altitude of 300 m) were
included in the study (Fig. 1). This area has a
temperate sub-alpine climate with warm sum-
mers (average 21C), annual precipitation of
1300–1600 mm, and cold winters (average 0.9C
with snow).
Acute Toxoplasma infection was detected in
47 (0.48%) of 9747 pregnant women during
the winter period (95% CI, 0.34–0.62), and in 26
(0.27%) of 9806 during the summer period
(95% CI, 0.17–0.37). Acute toxoplasmosis was
signiﬁcantly more frequent during winter than
Table 1. Incidence of acute toxoplasmosis in pregnant women in the central part of Slovenia during 1999–2004
Year Winter No. tested/No. infected (%) Spring No. tested/No. infected (%) Summer No. tested/No. infected (%) Autumn No. tested/No. infected (%)
1999–2000 1653 ⁄ 10 (0.60) 1824 ⁄ 7 (0.38) 1734 ⁄ 4 (0.23) 1957 ⁄ 10 (0.51)
2000–2001 2002 ⁄ 9 (0.45) 2104 ⁄ 10 (0.48) 2041 ⁄ 5 (0.24) 2067 ⁄ 8 (0.39)
2001–2002 2036 ⁄ 10 (0.49) 2143 ⁄ 11 (0.51) 1969 ⁄ 8 (0.41) 2063 ⁄ 3 (0.15)
2002–2003 1940 ⁄ 8 (0.41) 1907 ⁄ 9 (0.47) 1915 ⁄ 3 (0.16) 2026 ⁄ 11 (0.54)
2003–2004 2116 ⁄ 10 (0.47) 2110 ⁄ 5 (0.24) 2147 ⁄ 6 (0.28) 2327 ⁄ 6 (0.26)
Total 9747 ⁄ 47 (0.48) 10 088 ⁄ 42 (0.42) 9806 ⁄ 26 (0.27) 10 440 ⁄ 38 (0.36)
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summer (v2 = 6.192; p < 0.01), and also during
winter–spring (89 of 19 835 pregnant women)
than summer–autumn (64 of 20 246; v2 = 4.632;
p < 0.025) (Table 1).
Many factors may impact on the incidence of
toxoplasmosis, including the type of livestock
management and production, the hygiene stand-
ards of abattoirs and food processing, the density
of cats in the environment, the habits of human
consumers, the geographical location with respect
to altitude, and the prevailing climatic conditions.
It has been suggested that the incidence of acute
toxoplasmosis is likely to decline during warmer,
drier seasons because of the decreased number of
viable oocysts in the environment, but published
data regarding seasonal variations in acute
human toxoplasmosis are remarkably different
[4]. In contrast to the present ﬁndings that the
incidence of acute toxoplasmosis declines
during warmer, drier seasons, another study has
reported a decline during September–November
[5]. Surveillance data regarding toxoplasmatic
lymphadenopathy for England and Wales
showed no seasonal pattern [6], but Meenken
et al. [7] suggested that there may be a higher risk
of contracting toxoplasmosis in The Netherlands
during March–May. Similarly, the present study
showed that the incidence of acute Toxoplasma
infections in pregnant women in Slovenia was
signiﬁcantly higher during winter than summer,
and in winter–spring than summer–autumn.
Recent studies of human toxoplasmosis suggest
that oocyst-induced Toxoplasma infections in
humans are clinically more severe than the tissue
cyst-acquired infections [8–10]. In Slovenia, the
consumption of meat probably remains the same
throughout the year, so the higher incidence of
acute Toxoplasma infections in this area during the
colder months may be caused mainly by Toxo-
plasma oocysts excreted by cats. The higher
incidence of acute toxoplasmosis in pregnant
women during the colder months might be
caused by more frequent and closer contacts with
potentially Toxoplasma-infected cats, which prefer
to stay indoors during this period. The results
suggest that this phenomenon should be taken
into account, especially for pregnant women,
when formulating preventive measures for toxo-
plasmosis in this area.
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Fig. 1. The central area in Slovenia in which pregnant women were tested for acute toxoplasmosis.
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